How Common Are Finasteride Side Effects?
Sexual side effects are the most common, but they affect a minority of men and also occur on placebo. The original approval studies by the US Food and Drug Administration (FDA) examined 1,553 men in two 1-year trials; 1,215 of them continued in blinded extension studies for a second year. They provide important foundations for understanding side effects. [1] For details on efficacy, see Finasteride Efficacy and Clinical Studies, and for an overview of the substance, our page on finasteride as an active ingredient.
How Likely Are Sexual Side Effects?
The results on sexual side effects showed a surprising picture. The US prescribing information for finasteride 1 mg (2024 version) lists the following drug-related events for the first year:
| Side Effect | Finasteride (1 mg) | Placebo | Difference |
|---|---|---|---|
| Decreased Libido | 1.8% | 1.3% | 0.5% |
| Erectile Dysfunction | 1.3% | 0.7% | 0.6% |
| Ejaculation Disorders | 1.2% | 0.7% | 0.5% |
Sexual side effects in FDA approval studies in year 1 (drug-related; finasteride 1 mg, n=945; placebo, n=934) [14]
Important: The difference between finasteride and placebo was only 0.5 to 0.6 percentage points for each side effect. Even in the placebo group, sexual side effects occurred, so not every event can be attributed to the active ingredient; psychological factors (nocebo effect) may also play a role. [2] Overall, 36 of 945 men (3.8%) on finasteride reported at least one of these side effects, compared with 20 of 934 (2.1%) on placebo. The complaints resolved in the men who stopped the medication and, according to the prescribing information, in most of those who continued. By the fifth year of treatment, the incidence of each individual side effect fell to 0.3% or less. [14] The Swiss prescribing information classifies decreased libido and erectile dysfunction as common and ejaculation disorders as uncommon; over the following four years, the overall incidence of sexual side effects fell to 0.6%. [15]
An Italian study systematically examined this psychological factor with finasteride 5 mg (prostate dose). [2] The study design included 120 men with prostate enlargement divided into two groups. Group A received no information about possible sexual side effects, while Group B was informed about them with a brief statement. 107 of the 120 men completed the study. After 12 months, side effects were reported more often in the informed group: erectile dysfunction 30.9% vs. 9.6%, decreased libido 23.6% vs. 7.7%, and ejaculation disorders 16.3% vs. 5.7%. This suggests that expectation and counseling can influence reported side effect rates. The nocebo effect may help explain why different studies arrive at different rates. Factual information matters, but it should not create unnecessary anxiety. [5]
What Side Effects Does Finasteride Have?
The side effects of finasteride are well documented and occur with varying frequencies. The most frequently discussed side effects concern sexual function. [6] A meta-analysis of 15 randomized, placebo-controlled trials (4,495 participants) found a 1.57-fold risk of sexual dysfunction with 5-alpha-reductase inhibitors (95% confidence interval 1.19 to 2.08), and a 1.66-fold risk for finasteride 1 mg per day (1.20 to 2.30). [13] FDA studies report 1.8% compared to 1.3% in the placebo group for decreased libido. [14] The higher rates in some studies are partly explainable by the nocebo effect. [2] The absolute frequencies depend on the study, the dose and how side effects were collected. In most affected individuals, symptoms are reversible after discontinuation and often self-limiting, meaning they disappear during treatment. [14]
Finasteride and Fertility
If you are planning a child, semen quality is usually the first question. For semen quality, a randomized trial in 99 healthy men is available. It examined finasteride 5 mg (five times the hair-loss dose) and dutasteride 0.5 mg over one year. [3] With finasteride, total sperm count was 34.3% lower than at baseline after 26 weeks, 16.2% lower after 52 weeks and 6.2% lower 24 weeks after the end of treatment; from week 52 the decrease was no longer statistically significant. Sperm motility was reduced by 6 to 12%, also at follow-up. The authors describe the changes as mild and appearing reversible after discontinuation. [3] With finasteride 1 mg, median ejaculate volume fell by 0.3 mL (11%) in a 48-week study, compared with 0.2 mL (8%) on placebo. [14] According to MotherToBaby, only small amounts of finasteride are found in semen, and exposure through sex is not expected to harm a pregnancy. [10] If you are actively trying to conceive, still discuss use and possible discontinuation with a physician.
Breast Changes
A rare but described side effect is gynecomastia (breast enlargement); case reports exist. [4] In the clinical studies with finasteride 1 mg, breast tenderness and enlargement did not differ from placebo. After market launch, both were reported, and their frequency cannot be reliably estimated. The frequency with the higher 5-mg dose (prostate treatment) is 0.5% in the first year (placebo 0.1%) and 1.8% in years 2 to 4 (placebo 1.1%). [14] With topical application, the risk may be lower when systemic exposure is lower. [12] You should have changes in the breast such as lumps, pain or nipple discharge checked by a doctor promptly. [14]
When Do Finasteride Side Effects Start?
The US prescribing information does not give a typical time of onset. The data do show when complaints were reported most often, namely in the first year of treatment. By the fifth year, the incidence of each individual sexual side effect had fallen to 0.3% or less. [14] The Swiss prescribing information describes a decline in sexual side effects to 0.6% overall over the following four years. [15]
Take changes in mood seriously throughout treatment. According to the November 2025 notice, treatment should be stopped and medical advice sought immediately in case of depressed mood, depression or suicidal thoughts. [9]
Are Finasteride Side Effects Permanent?
For most people, no. In the approval studies, complaints resolved in men who stopped and in most of those who continued. [14] Swissmedic points out, however, that in some cases side effects persist after discontinuation, mainly sexual dysfunction. [7] How often this happens is not known. [15]
Post-Finasteride Syndrome (PFS)
Post-finasteride syndrome describes persistent symptoms during or after treatment with finasteride. [8] Some affected individuals report sexual, neurological, physical and psychological complaints (such as depressive moods) that supposedly persist even after discontinuation. [8] However, the study data is unclear: a review points out that many studies capture adverse events inadequately [8], and according to Swissmedic the underlying pathophysiology is not fully understood. [7] There are no reliable figures on how often persistent symptoms occur; the Swiss prescribing information gives the frequency of sexual dysfunction persisting after discontinuation as not known. [15] This makes it difficult to draw definitive conclusions.
Swissmedic Position
Swissmedic points out that finasteride can in some cases cause long-lasting side effects that persist after discontinuation, mainly sexual dysfunction. Healthcare professionals must report serious or previously unknown side effects to Swissmedic. [7]
In 2025, new warnings regarding psychological side effects, including suicidal ideation, were added: In November 2025, a notice to healthcare professionals (DHPC) agreed with Swissmedic was published. It names suicidal thoughts as a side effect of orally used finasteride and introduces a patient card for medicines containing 1 mg finasteride. In case of depressed mood, depression or suicidal thoughts, treatment should be stopped and medical advice sought. [9]
What Happens When You Stop Finasteride?
When you stop finasteride, the effect on hair is lost. According to the US prescribing information, the effect reverses within 12 months of stopping. In the approval studies, the additional hair count in men who switched to placebo after one year had disappeared 12 months later. [14] The effect of finasteride on androgenetic alopecia therefore lasts only as long as it is used.
And the side effects? In men who stopped because of sexual side effects, the complaints resolved in the approval studies. [14] The lower sperm count with finasteride 5 mg also appeared reversible after stopping. [3] In some cases, however, complaints persist, as described above under post-finasteride syndrome. [7] [15]
Whether and when to stop is best discussed with your doctor, for example in case of side effects, plans to conceive or a lack of effect. Your doctor can also assess whether another dosage form is an option. The exception is depressed mood, depression or suicidal thoughts, in which case treatment should be stopped immediately and medical advice sought right away. [9]
Does Topical Finasteride Have Fewer Side Effects?
In a randomized 24-week phase III trial (with manufacturer involvement), a topical finasteride spray showed a lower systemic DHT reduction [12] and numerically lower rates of sexual side effects [11] than oral finasteride 1 mg. Whether topical finasteride is better or safer than the tablet is covered in detail in our guide topical vs oral finasteride.
| Measure | Topical (0.25%) | Oral (1 mg) |
|---|---|---|
| Sexual side effects [11] | 2.8% | 4.8% |
| Serum DHT reduction [12] | 34.5% | 55.6% |
| Maximum plasma finasteride concentration [12] | more than 100 times lower | Reference |
Comparison of side effect profile topical vs. oral in a phase III trial (24 weeks) [11][12]
According to the Swiss prescribing information for the approved finasteride spray, treatment-related sexual side effects occurred in this trial in 2.8% of participants on the spray, 3.3% on placebo and 4.8% on oral finasteride 1 mg. [11] The study authors conclude from the lower plasma concentration and smaller DHT reduction that systemic, DHT-related sexual side effects are less likely with the spray. [12]
With ultra-low dose topical finasteride (0.005%), the systemic uptake may be lower. How relevant this is in an individual case depends on the product, amount, area, and application.
Contraindications and Precautions
There are certain situations where finasteride should not be used or special caution is required. Finasteride is absolutely contraindicated in women who are or may be pregnant and with known hypersensitivity to finasteride; it is not indicated for women. [15] It is also not approved for children and adolescents under 18 years, as insufficient data exists regarding safety and efficacy. [14] [15]
Special caution is required with an active desire to conceive; use and the timing of a possible discontinuation should be discussed with a physician beforehand. Caution is also needed with pre-existing sexual dysfunction, depression or anxiety disorder, and a discussion with the physician is important, because according to the November 2025 notice, sexual dysfunction can contribute to mood changes, including suicidal thoughts. [9] With liver insufficiency, caution is needed as finasteride is hepatically metabolized. [14] No data exist for use in hepatic insufficiency, so no dosage recommendations can be made. [15]
Pregnancy and Critical Warning
Risk During Pregnancy
Finasteride can cause malformations of the external genitalia in male fetuses. [15] Even skin contact with broken or crushed tablets can be dangerous because of possible absorption of the active ingredient: women who are pregnant or may be pregnant must neither touch nor take such tablets. Intact, coated tablets prevent contact with the active ingredient during normal handling. [15] MotherToBaby considers it unlikely that enough of the medication passes through the skin to endanger a pregnancy. [10] With topical finasteride, pregnant women or women who may become pregnant, and children and adolescents under 18, must not come into contact with treated skin areas. [11]
Risk Minimization with Finasteride
There are various approaches to minimize the risk of side effects and improve tolerability. A conscious attitude is central: inform yourself objectively but avoid excessive rumination about possible side effects, as the nocebo effect is real and can amplify symptoms. Keep a symptom diary and discuss concerns with your doctor instead of abruptly discontinuing. This does not apply to depressed mood, depression or suicidal thoughts: in that case treatment should be stopped and medical advice sought immediately. [9] If other side effects occur, your doctor decides whether to adjust the dose, choose an alternative form of administration or end the treatment.
Topical finasteride may be an option when systemic absorption should be reduced. How much the risk changes depends on concentration, amount, application area, and product. The dosage form should therefore be selected by a physician.
How Dangerous Is Finasteride Really?
For most men, finasteride causes no sexual side effects, but it is not entirely harmless. Besides sexual complaints that are usually temporary, there are persistent symptoms after stopping in some cases and warnings about psychological side effects, including suicidal thoughts. [7] [9] Converted to 100 men, the figures from the approval studies look like this.
Realistic Risk Assessment
Of 100 men taking 1 mg finasteride orally, about 96 will report no drug-related sexual side effect in the first year. About 4 men may experience sexual side effects (about 2 on placebo); the complaints resolved in the men who stopped. About 1 discontinues because of them (1.2%; placebo 0.9%). [14] There are no reliable figures on the frequency of persistent symptoms after discontinuation. [7] With topical application, systemic absorption is lower [12]; how this affects side effects in an individual case remains a matter for medical assessment.
Conclusion for Informed Decision-Making
Finasteride is a well-studied medication. In the approval studies, 3.8% of men on finasteride 1 mg reported at least one drug-related sexual side effect in the first year, compared with 2.1% on placebo. The complaints resolved in the men who stopped treatment and in most of those who continued. [14] A meta-analysis also shows an increased relative risk of sexual dysfunction [13], and Swissmedic points to possible persistent as well as psychological side effects. [7][9]
The nocebo effect can play a role, because anticipatory anxiety can amplify reported symptoms. [2] In a phase III trial, sexual side effects occurred in 2.8% of participants using a topical spray, 3.3% on placebo and 4.8% with oral intake. [11]
The decision for or against finasteride should be based on facts and physician assessment. Topical finasteride may be an option with lower systemic absorption, but it does not replace an individual benefit-risk assessment. For more information, see our articles on Finasteride Efficacy & Studies, Finasteride Topical vs. Oral and Finasteride Prescription Switzerland. Start your online consultation or learn more about hair loss causes.
Facts and figures
- 1,553 men took part in the two one-year approval studies, and 1,215 of them continued treatment in the second year. [1]
- 3.8% of men on finasteride, compared with 2.1% on placebo, reported at least one drug-related sexual side effect in the first year. [14]
- 0.5 to 0.6 percentage points separated finasteride from placebo for reduced libido, erectile dysfunction and ejaculation disorders. [14]
- 1.2% of men stopped treatment because of sexual side effects, compared with 0.9% on placebo. [14]
- No more than 0.3% of men had any single sexual side effect by the fifth year of treatment. [14]
- A 1.57-fold risk of sexual dysfunction with 5-alpha reductase inhibitors emerged from a meta-analysis of 15 randomised trials with 4,495 participants. [13]
- 30.9% versus 9.6% of men reported erectile dysfunction in a study of the prostate dose, depending on whether they had been told about possible side effects beforehand. [2]
- 2.8% with the topical spray, 3.3% on placebo and 4.8% with oral intake reported sexual side effects in a 24-week phase III trial. [11]
- Serum DHT fell by 34.5% with the spray and by 55.6% with oral intake in the same trial. [12]
Frequently asked questions
How likely are sexual side effects with finasteride?
In the approval studies, 3.8% of men on finasteride 1 mg reported at least one drug-related sexual side effect in the first year, compared with 2.1% on placebo. The complaints resolved in the men who stopped treatment and, according to the prescribing information, in most of those who continued.
What happens when you stop finasteride?
The effect on hair is lost. According to the US prescribing information, the effect reverses within 12 months of stopping. Whether and when to stop is best discussed with your doctor. With depressed mood or suicidal thoughts, however, stop immediately and seek medical advice right away.
Do the side effects go away after stopping?
For most people, yes. Swissmedic points out, however, that in some cases complaints can persist after stopping, above all sexual dysfunction. There are no reliable figures on how often such persistent symptoms occur.
Does topical finasteride have fewer side effects than tablets?
In a 24-week phase III trial, sexual side effects occurred in 2.8% of participants using a topical spray, 3.3% on placebo and 4.8% with oral intake. Systemic absorption was markedly lower with the spray. Which form suits you is decided by the doctor.
What should I do if my mood changes on finasteride?
If you experience depressed mood, depression or suicidal thoughts, treatment should be stopped and medical advice sought immediately. This is set out in a communication to healthcare professionals agreed with Swissmedic in November 2025.
Can I use finasteride if I want to have children?
If you are actively trying for a child, discuss the treatment and a possible time to stop with a doctor first. In a study using five times the dose, sperm count was temporarily lower, and the changes appeared reversible after stopping. Women who are pregnant or could become pregnant must not touch broken or crushed tablets.
Ingredients in this guide
Read more about how each ingredient works, its side effects and the research on the ingredient pages.
References
- [1]Kaufman KD, Olsen EA, Whiting D, et al. (1998). Finasteride in the treatment of men with androgenetic alopecia. Journal of the American Academy of Dermatology. doi.org/10.1016/s0190-9622(98)70007-6
- [2]Mondaini N, Gontero P, Giubilei G, et al. (2007). Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon? Journal of Sexual Medicine. doi.org/10.1111/j.1743-6109.2007.00563.x
- [3]Amory JK, Wang C, Swerdloff RS, et al. (2007). The Effect of 5α-Reductase Inhibition with Dutasteride and Finasteride on Semen Parameters and Serum Hormones in Healthy Men. Journal of Clinical Endocrinology & Metabolism. doi.org/10.1210/jc.2006-2203
- [4]Ramot Y, Czarnowicki T, Zlotogorski A. (2009). Finasteride-induced Gynecomastia: Case Report and Review of the Literature. International Journal of Trichology. doi.org/10.4103/0974-7753.51930
- [5]Mysore V. (2012). Finasteride and sexual side effects. Indian Dermatology Online Journal. doi.org/10.4103/2229-5178.93496
- [6]Fertig RM, Gamret AC, Darwin E, Gaudi S. (2017). Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: a comprehensive review. Dermatology Online Journal. doi.org/10.5070/D32311037240
- [7]Swissmedic. (2020). Finasterid: Persistierende Nebenwirkungen. Swissmedic. swissmedic.ch (Accessed 13.10.2026)
- [8]Traish AM. (2020). Post-finasteride syndrome: a surmountable challenge for clinicians. Fertility and Sterility. doi.org/10.1016/j.fertnstert.2019.11.030
- [9]Swissmedic. (2025). DHPC – Finasterid / Dutasterid: Neue Massnahmen zur Minimierung des Risikos für Suizidgedanken. Swissmedic. swissmedic.ch (Accessed 13.10.2026)
- [10]MotherToBaby. (2026). Finasteride. MotherToBaby, Organization of Teratology Information Specialists (OTIS). mothertobaby.org (Accessed 13.10.2026)
- [11]Bailleul (Suisse) SA. (2022). Fynzur Spray 2,275 mg/ml, Fachinformation. Swissmedicinfo. swissmedicinfo.ch (Accessed 13.10.2026)
- [12]Piraccini BM, Blume-Peytavi U, Scarci F, et al. (2022). Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. Journal of the European Academy of Dermatology and Venereology. doi.org/10.1111/jdv.17738
- [13]Lee S, Lee YB, Choe SJ, Lee WS. (2019). Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis. Acta Dermato-Venereologica. doi.org/10.2340/00015555-3035
- [14]Organon LLC. (2024). PROPECIA (finasteride) tablets, prescribing information. U.S. Food and Drug Administration / DailyMed. dailymed.nlm.nih.gov (Accessed 13.10.2026)
- [15]Organon GmbH. (2026). Propecia® 1 mg Filmtabletten, Fachinformation. Swissmedicinfo. swissmedicinfo.ch (Accessed 13.10.2026)
Our guides are based on scientific sources, cited in the text. Learn about our standards
